Interestingly, we discovered that PPAT and PAICS knockdown substantially diminished pyruvate kinase activity that is comparable to the PKM2 knockdown suggesting that PKM2 could be an important contributor of the pyruvate kinase activity in lung cancer cell lines. This evidence concerns the gene PPAT and lung carcinoma.